# Shanrong Biotechnology Corp. (SRBT)

> Financial Services · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/SRBT/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2024 | $ 0 | $ -24.7K | N/A | $ 0 | $ -676.2K |
| 2023 | $ 0 | $ -34.9K | $ -34.9K | $ 0 | $ -660.3K |
| 2022 | $ 0 | $ -88.2K | $ -86.2K | $ 0 | $ -77.0K |
| 2021 | N/A | N/A | N/A | $ 0 | $ 3.0K |
| 2009 | $ 2.01M | $ -7.69M | $ -1.19M | $ 1.91M | $ -3.98M |
| 2008 | $ 0 | $ -59.8K | $ -38.2K | $ 0 | $ -17.1K |
| 2007 | $ 0 | $ -363 | $ -30.5K | $ 0 | $ 22.5K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | -1.00 |
| Current Ratio | 0.04 |

## Other views

- [Metrics](https://sponda.capital/en/SRBT.md)
- [Charts](https://sponda.capital/en/SRBT/charts.md)
- [Compare](https://sponda.capital/en/SRBT/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.